These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 778448)

  • 21. Growth and toxin production of Clostridium botulinum types E, nonproteolytic B, and F in nonirradiated and irradiated fisheries products in the temperature range of 38 degrees to 50 degrees F. TID-25231.
    Eklund MW; Poysky FT
    TID Rep; 1969 Jan; ():1-33. PubMed ID: 4905817
    [No Abstract]   [Full Text] [Related]  

  • 22. BotR/A and TetR are alternative RNA polymerase sigma factors controlling the expression of the neurotoxin and associated protein genes in Clostridium botulinum type A and Clostridium tetani.
    Raffestin S; Dupuy B; Marvaud JC; Popoff MR
    Mol Microbiol; 2005 Jan; 55(1):235-49. PubMed ID: 15612931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum].
    Gimenez DF; Ciccarelli AS
    Medicina (B Aires); 1972; 32(6):596-606. PubMed ID: 4576316
    [No Abstract]   [Full Text] [Related]  

  • 24. Phage-conversion to hemagglutinin production in Clostridium botulinum types C and D.
    Oguma K; Iida H; Shiozaki M
    Jpn J Med Sci Biol; 1977 Feb; 30(1):40-3. PubMed ID: 406437
    [No Abstract]   [Full Text] [Related]  

  • 25. Proceedings: Immunological specificities of Clostridium botulinum type C and D toxins.
    Shimizu T; Izumi N; Kondo H
    Jpn J Med Sci Biol; 1975; 28(5-6):298-301. PubMed ID: 1228237
    [No Abstract]   [Full Text] [Related]  

  • 26. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Properties of toxins present in the spores of the Clostridium genus with special reference to Cl. botulinum].
    Rymkiewicz D
    Postepy Hig Med Dosw; 1973; 27(4):407-31. PubMed ID: 4581733
    [No Abstract]   [Full Text] [Related]  

  • 28. The origin, structure, and pharmacological activity of botulinum toxin.
    Simpson LL
    Pharmacol Rev; 1981 Sep; 33(3):155-88. PubMed ID: 6119708
    [No Abstract]   [Full Text] [Related]  

  • 29. [Identification of strain B 657 of Clostridium botulinum].
    Giménez DF; Giménez JA
    Rev Argent Microbiol; 1983; 15(1):51-5. PubMed ID: 6400761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and taxonomic significance of bacteriophages for non-proteolytic Clostridium botulinum.
    Sugiyama H; King GJ
    J Gen Microbiol; 1972 May; 70(3):517-25. PubMed ID: 4556256
    [No Abstract]   [Full Text] [Related]  

  • 31. Bacteriophage and the toxigenicity of Clostridium botulinum type C.
    Eklund MW; Poysky FT; Reed SM; Smith CA
    Science; 1971 Apr; 172(3982):480-2. PubMed ID: 4927679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [STUDIES ON CLOSTRIDIUM BOTULINUM TYPE E. 3. PRODUCTION OF HIGHLY ACTIVE TOXIC BOTULINUM ANTIGENS IN CELLOPHANE BAG CULTURES].
    MEISEL H; ALBRYCHT H; RYMKIEWICZ D; SWITALSKA A; TREMBOWLER P
    Med Dosw Mikrobiol; 1964; 16():323-30. PubMed ID: 14305628
    [No Abstract]   [Full Text] [Related]  

  • 33. [ANTIGENIC SPECIFICITY OF CL. BOTULINUM TYPES C, D, E].
    SHEVELEV VM; VORONOVA ZA; REZEPOV FF
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Mar; 41():65-9. PubMed ID: 14187965
    [No Abstract]   [Full Text] [Related]  

  • 34. Restoring bacterial toxigenicity.
    Lederberg J
    Science; 1971 Jul; 173(3992):104-5. PubMed ID: 4932164
    [No Abstract]   [Full Text] [Related]  

  • 35. [A bacteriophage in a culture of Cl. botulinum type C].
    Vinet G; Berthiaume L; Fredette V
    Rev Can Biol; 1968 Mar; 27(1):73-4. PubMed ID: 4883802
    [No Abstract]   [Full Text] [Related]  

  • 36. Proceedings: Antigenicity of converting phages obtained from Clostridium botulinum types C and D.
    Oguma K; Iida H; Shiozaki M; Inoue K
    Jpn J Med Sci Biol; 1975; 28(5-6):301-4. PubMed ID: 778448
    [No Abstract]   [Full Text] [Related]  

  • 37. Proceedings: Bacteriophages and toxigenicity in Clostridium botulinum types C and D.
    Oguma K; Iida H; Inoue K
    Jpn J Med Sci Biol; 1975 Feb; 28(1):63-6. PubMed ID: 1099282
    [No Abstract]   [Full Text] [Related]  

  • 38. Antigenicity of converting phages obtained from Clostridium botulinum types C and D.
    Oguma K; Iida H; Shiozaki M; Inoue K
    Infect Immun; 1976 Mar; 13(3):855-60. PubMed ID: 773828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Toxigenicity and bacteriophage in Clostridium botulinum (author's transl)].
    Iida H
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():31-44. PubMed ID: 800280
    [No Abstract]   [Full Text] [Related]  

  • 40. Bacteriophages and Toxigencity in Clostridium Botulinum types C and D.
    Oguma K; Iida H; Inove K
    Schweiz Med Wochenschr; 1975 Dec; 105(51):548-52. PubMed ID: 766180
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.